期刊文献+

CVVH对MODS患者HMGBl介导的T淋巴细胞亚群变化的影响 被引量:5

Effects of continuous veno - venous hemofiltration on the changes of T cell subgroup mediated by HMGB1 in patients with multiple organ dysfunction syndrome
下载PDF
导出
摘要 目的探讨连续性静脉-静脉血液滤过(CVVH)对多器官功能障碍综合征(MODS)患者高迁移率族蛋白B1(HMGBl)表达和T淋巴细胞亚群的影响。方法40例符合MODS诊断标准的ICU患者,均行CVVH治疗。于CVVH前、CVVH治疗8h及结束治疗后8h分别测定HMGBl和T淋巴细胞亚群。结果HMGBl能影响外周血T淋巴细胞亚群变化。CVVH治疗后血清TNF-α、IL-1、IL-6及HMGBl浓度降低,CD3+/CD4+、CD3-/CDl6+上升,CD3+/CD8+下降;TH/TS比值升高,且至16h差异无统计学意义(P=0.811)。结论CVVH可降低MODS患者的HMGBl浓度,调节HMGBl介导的细胞免疫紊乱,重建免疫平衡。 Objective To investigate the effects of continuous veno - venous hemofihration (CVVH) on the levels of serum high mobility group box- 1 protein (HMGB1) and the changes of each T -lymphocyte subset in patients with muhiple organ dysfunction syndrome (MODS). Methods Forty patients with MODS in intensive care unit were scheduled for the treatment with CVVH, the levels of HMGB1 and the percent of each T - lymphocyte subset were identified on the point of pre - CVVH (0 h), the eighth hour of CVVH (8 h) and 8 h after CVVH therapy (16 h). Results The percent of peripheral blood T - lymphocyte subsets were altered by the stimulation of HMGB1. After CVVH treatment, the levels of serum TNF alpha, IL - 1, IL - 6 and HMGB1 were decreased, the percent of CD3 +/CD4 + , CD3 -/CD16+ was increased, and the percent of CD3 +/CD8 + was decreased; but there was an continuous increasing in ratio of TH/TS. Conclusion CVVH could reduce the HMGB1 levels of patients with MODS, regulate cellular immune disorder mediated by HMGB1, and rebuild the immune balance.
出处 《中国急救医学》 CAS CSCD 北大核心 2014年第1期75-78,共4页 Chinese Journal of Critical Care Medicine
基金 贵州省科技厅联合基金项目(黔科合IJS字[2011]039)
关键词 连续性静脉一静脉血液滤过(CVVH) 多器官功能障碍综合征(MODS) 高迁移率族蛋白B1(HMGB1) T淋巴细胞亚群 Continuous veno -venous hemofiltration (CVVH) Muhiple organ dysfunctionsyndrome(MODS) High mobility group box - 1 protein ( HMGB1 ) T -lymphocyte subsets
  • 相关文献

参考文献13

  • 1Abdo AA,Castellanos R,Rocha M. Continuous venovenoushemodiafiltration in patients with multiple organ dysfunction syndrome in an intensive care unit[J].MEDICC Rev,2012,(3):26-30.
  • 2Fang WH,Yao YM,Shi ZG. The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J].{H}SHOCK,2002,(4):329-333.
  • 3Bone RC,Balk RA,Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine[J].{H}CHEST,1992.1644-1655.
  • 4王忠堂,姚咏明,盛志勇.HMGB1对淋巴细胞增殖、凋亡及Th1/Th2、Tc1/Tc2漂移的影响[J].细胞与分子免疫学杂志,2008,24(4):324-327. 被引量:7
  • 5Eskici ZM,Aokgqzs,Pipkin N. High mobility group B1 levels in sepsis and disseminated intravascular coagulation[J].{H}ACTA BIOCHIMICA POLONICA,2012,(4):561-566.
  • 6Wang H,Bloom O,Zhang M. HMG-1 as a late mediator of endotoxin lethality in mice[J].{H}SCIENCE,1999,(5425):248-251.
  • 7Andersson U,Wang H,Palmblad K. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes[J].{H}Journal of Experimental Medicine,2000,(4):565-570.
  • 8Park JS,Arcaroli J,Yum HK. Activation of gene expression in human neutrophils by high mobility group box 1 protein[J].{H}American Journal of Physiology Cell Physiology,2003,(4):C870-C879.
  • 9Unterwalder N,Meisel C,Sawatis K. High-Mobility group box-1 protein serum levels do not reflect monocytic function in patients with sepsis-induced immunosuppression[J].{H}Mediators of Inflammation,2010.1-6.
  • 10Yasuda N,Goto K,Yamamoto S. Removal of 17 cytokines,HMGB1,and albumin by continuous hemofiltration using a cellulose triacetate membrane:an ex vivo study[J].{H}Journal of Surgical Research,2012,(1):226-231.

二级参考文献20

共引文献37

同被引文献66

  • 1吴淡森,石松菁.多器官功能衰竭救治进展[J].创伤与急诊电子杂志,2014,2(2):6-10. 被引量:6
  • 2王海燕.肾脏病学[M]第2版[M].北京:人民卫生出版社,1998.103-104.
  • 3Marshall JC. Critical illness is an iatrogenic disorder [ J]. Crit Care Med, 2010, 38( 10 Suppl) : $582-589.
  • 4Varghese H J, MacKenzie LT, Groom AC, et al. Mapping of the functional microcirculation in vital organs using contrast enhanced in vivo video microscopy[ J]. Am J Physiol Heart Circ Physiol, 2005, 288(1) : H185 -193.
  • 5Bone RC, Balk RA, Cerra FB, et al. Definitions for Sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, the ACCP/SCCM Consensus Conference Committee, American Collegre of Chest Physicianslsociety of Critical Care Medicine[J]. Chest, 1992, 101(6): 1644-1655.
  • 6Kenney EM, Rozanski EA, Rush JE, et al. Association between outcome and organ system dysfunction in dogs with sepsis: 114 ca- ses(2003 - 2007 ) [ J]. J Am Vet Med Assoc, 2010, 236 ( 1 ) : 83 - 87.
  • 7Ferrari S, Finelli P, Rocchi M, et al. The active gene that en- codes human high mobility group 1 protein ( HMG1 ) contains in- trons and maps to chromosome 13[J]. Genomics, 1996, 35(2) : 367 - 371.
  • 8Stros M. HMGB proteins:interactions with DNA and chromatin [J]. Bioehim Biophys Acta, 2010, 1799(1 -2) : 101 -113.
  • 9Harris HE, Andersson U, Pisetsky DS. HMGBI: a multifunetional alarmin driving autoimmune and inflammatory disease [ J ]. Nat Rev Rheumatol, 2012, 8(4) : 195 -202.
  • 10Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection [ J ]. Annu Rev Immunol, 2011 , 29 : 139 - 162.

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部